Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients

Abstract

Background The COVID-19 pandemic induced rapid adoption of telemedicine services for neuro-oncology patients at an increased risk of infection. Neuropsychological assessment is important to neuro-oncology care yet challenging to complete outside of a structured testing environment. Teleneuropsychology (TNP) has been explored in limited populations and proven feasible and reliable. Conducting TNP visits directly to patients' home (DTH) had minimal prior study. Methods We used two voluntary surveys to examine acceptance (patients) and feasibility (providers) of DTH-TNP at two regionally diverse medical institutions providing neuropsychological services to neuro-oncology patients from April to September 2020. Results A total of 119 patients were scheduled during the study period, 79 of whom completed neuropsychological testing via DTH-TNP. Neuropsychology providers completed surveys on 68 of these encounters (86%). In 98% of cases, neuropsychologists were able to achieve or partially achieve the individually defined goals of their assessment. Common problems reported included patient dysregulation (16%) and slow/unreliable internet (15%). Of the 52 patients who responded, 98% were satisfied with the DTH-TNP experience and 92% would recommend the virtual visit to others. All respondents felt understood by the examiner (100%) and the majority denied technical difficulties (90%), communication challenges (94%), or privacy concerns (98%). Patients reported reduced risk of infection and saved travel time as favorable aspects of DTH-TNP. Conclusions These preliminary results suggest neuro-oncology patients find DTH-TNP acceptable and neuropsychologists find it a feasible practice, while also recognizing its limitations. Results suggest that further study of DTH-TNP (e.g., reliability, validity) for neuro-oncology patients is warranted.

A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects

“… 61 , 62 , 63 , 64 To our knowledge, there have not yet been published studies examining the reliability and validity of teleneuropsychology in breast cancer, but its feasibility and acceptability have been demonstrated in other cancer populations. 65 …”

“…However, there is research supporting the equivalency of in‐person and remote cognitive testing and the use of teleneuropsychology during the pandemic has been accepted as a reliable and valid alternative to in‐person assessment 61–64 . To our knowledge, there have not yet been published studies examining the reliability and validity of teleneuropsychology in breast cancer, but its feasibility and acceptability have been demonstrated in other cancer populations 65 …”

Success of home-to-home tele-neuropsychology (TeleNP) in deep brain stimulation (DBS) candidacy assessments: COVID-19 and beyond

“…The validity of in-home TeleNP testing has also been examined indicating that telehealth scores do not differ significantly from in-person testing, which further supports the use of our current testing model [ 26 , 27 ]. A study conducted by Gardner and colleagues, was the first to demonstrate acceptability and feasibility of direct to home TeleNP in a neuro-oncology clinical sample [ 28 ]. This study demonstrated that TeleNP is a feasible practice, while also recognizing limitations in assessing motor and executive functioning.…”

The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice

“…The demonstrable success of telemedicine across multiple fields of neurosurgery has validated its continued use over the last 24 months. Telemedicine applications were successful in teleneuropsychology, telestroke, and tele-ICU rounding [ 4 – 6 ]. For example, our center’s retrospective cohort study determined that telemedicine led to a faster diagnosis of stroke, more frequent administration of tPA, and better long-term outcomes [ 5 , 7 , 8 ].…”